RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31706988http://www.w3.org/2000/01/rdf-schema#comment"The dual expression of CD5 and MYC protein (DECM) on B-lymphocytes may arise at a specific stage of de novo diffuse large B-cell lymphoma (DLBCL). This study retrospectively reviewed 210 patients with de novo DLBCL at the Affiliated Hospital of Jiangnan University between 2006 and 2017. DECM was significantly correlated with a worse prognosis than that in either the CD5+ or MYC+ or CD5-MYC- patients. Furthermore, patients with DECM showed a similar outcome to MYC+BCL2+ lymphoma patients who have extremely poor survival rates. Multivariate analysis demonstrated that DECM was a significant independent predictor for overall survival (P < .0001) and progression-free survival (P < .0001) in DLBCL. DLBCL patients with DECM showed significantly inferior clinical outcomes compared to the CD5+, MYC+ or CD5-MYC- patients. Combinational therapeutic modalities might be a candidate approach to improve the prognosis of these patients."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.org/dc/terms/identifier"doi:10.1016/j.yexmp.2019.104326"xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Zhang Y."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Wu S."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Hong T.T."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Zhou X.Y."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Wu X.H."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Lu T.X."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Qi X.W."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Cai D.Y."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/author"Hua H.Y."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/name"Exp Mol Pathol"xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/pages"104326"xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/title"CD5+MYC+ predicts worse prognosis in diffuse large B-cell lymphoma."xsd:string
http://purl.uniprot.org/citations/31706988http://purl.uniprot.org/core/volume"112"xsd:string
http://purl.uniprot.org/citations/31706988http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31706988
http://purl.uniprot.org/citations/31706988http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31706988
http://purl.uniprot.org/uniprot/#_A0A0B4J1R1-mappedCitation-31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31706988
http://purl.uniprot.org/uniprot/#_A0A384ME09-mappedCitation-31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31706988
http://purl.uniprot.org/uniprot/#_A0N2G3-mappedCitation-31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31706988
http://purl.uniprot.org/uniprot/#_A0A224B085-mappedCitation-31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31706988
http://purl.uniprot.org/uniprot/#_B3CJ86-mappedCitation-31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31706988
http://purl.uniprot.org/uniprot/#_B3CJ87-mappedCitation-31706988http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31706988